RN-1665

CAS No. 1803003-65-7

RN-1665( —— )

Catalog No. M37081 CAS No. 1803003-65-7

RN-1665 is a potent and selective TRPV4 receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 157 In Stock
10MG 216 In Stock
25MG 357 In Stock
50MG 463 In Stock
100MG 637 In Stock
200MG 840 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RN-1665
  • Note
    Research use only, not for human use.
  • Brief Description
    RN-1665 is a potent and selective TRPV4 receptor antagonist.
  • Description
    RN-1665 is a potent and selective TRPV4 receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRP/TRPV Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1803003-65-7
  • Formula Weight
    513.54
  • Molecular Formula
    C20H24F5N3O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=CC=C(S(N2CCN(C(C)C)CC2)(=O)=O)C=C1)C3=CC=C(S(F)(F)(F)(F)F)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ABT 102

    ABT 102 is a selective antagonist of transient receptor potential vanilloid 1 (TRPV1) receptor.

  • HhAntag

    HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.

  • Pyr6

    Pyr6 is a selective TRPC3 inhibitor with IC50 of 0.49 uM(Ca2+ influx inhibition in thapsigargin depleted native RBL-2H3 cells).Pyr6 is an inhibitor of Ca2+ entry, which displays higher potency to inhibit Ca2+ entry mediated by CRAC channel than by TRPC3.Pyr3 is selective inhibitor of TRPC3, inhibited Orai1- and TRPC3-mediated Ca(2+) entry and currents as well as mast cell activation with similar potency.?